Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04652570
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-16
First Post:
2020-11-23
Brief Title:
Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
Sponsor:
Tenet Medicines
Organization:
Tenet Medicines
Study Overview
Official Title:
A Phase 1b2a Study of VB119 in Adult Subjects With Primary Membranous Nephropathy
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a Phase 1b2a open-label sequential-cohort dose escalation and dose expansion study to evaluate the safety tolerability PK and PD of VB119 in subjects with primary MN
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None